{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:17:09Z","timestamp":1740115029522,"version":"3.37.3"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018531","name":"Major Science and Technology Projects in Yunnan Province","doi-asserted-by":"publisher","award":["202002AA100009"],"award-info":[{"award-number":["202002AA100009"]}],"id":[{"id":"10.13039\/501100018531","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.vaccine.2024.02.042","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T13:09:06Z","timestamp":1708520946000},"page":"1973-1979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunogenicity and lot-to-lot consistency of booster shot with Sabin inactivated poliomyelitis vaccine in Chinese children aged 18\u201324 Months: A phase \u2163 clinical trial"],"prefix":"10.1016","volume":"42","author":[{"given":"Qiongzhou","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenmei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youjian","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiju","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Pu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchun","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"39","key":"10.1016\/j.vaccine.2024.02.042_b0005","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1016\/j.vaccine.2014.07.029","article-title":"Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants","volume":"32","author":"Verdijk","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.042_b0010","first-page":"1","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, November 2013: conclusions and recommendations","volume":"89","author":"World Health Organization","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2024.02.042_b0015","first-page":"1","article-title":"Polio endgame strategy 2019\u20132023: eradication, integration, certification and containment","author":"World Health Organization","year":"2018","journal-title":"Glob Polio Erad Initiat"},{"key":"10.1016\/j.vaccine.2024.02.042_b0020","first-page":"1","article-title":"Immuno-persistence of the different primary polio vaccine schedules and immunogenicity of the booster dose by sabin inactivated or bivalent oral poliovirus vaccine in children aged 4 years: an open-label, randomised, controlled phase 4 trial in China","volume":"34","author":"Tang","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"issue":"9","key":"10.1016\/j.vaccine.2024.02.042_b0025","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S1473-3099(19)30738-8","article-title":"Immunogenicity of three sequential schedules with Sabin inactivated poliovirus vaccine and bivalent oral poliovirus vaccine in Zhejiang, China: an open-label, randomised, controlled trial","volume":"20","author":"He","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"40","key":"10.1016\/j.vaccine.2024.02.042_b0030","doi-asserted-by":"crossref","first-page":"6274","DOI":"10.1016\/j.vaccine.2020.07.042","article-title":"Immunogenicity and safety of different sequential schedules of Sabin strain-based inactivated poliovirus vaccination: A randomized, controlled, open-label, phase IV clinical trial in China","volume":"38","author":"Yan","year":"2020","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2024.02.042_b0035","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.vaccine.2021.01.027","article-title":"Immunogenicity and safety of the inactivated poliomyelitis vaccine made from Sabin strains in a phase IV clinical trial for the vaccination of a large population","volume":"39","author":"Jiang","year":"2021","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.042_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-023-00642-w","article-title":"Evaluation of the immunization effectiveness of bOPV booster immunization and IPV revaccination","volume":"8","author":"Yu-Ping","year":"2023","journal-title":"npj Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2024.02.042_b0045","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/infdis\/jiz124","article-title":"Rapid Disappearance of Poliovirus Type 2 (PV2) Immunity in Young Children Following Withdrawal of Oral PV2-Containing Vaccine in Vietnam","volume":"220","author":"Huyen","year":"2019","journal-title":"J Infect Dis"},{"issue":"6489","key":"10.1016\/j.vaccine.2024.02.042_b0050","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.aba1238","article-title":"Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine","volume":"368","author":"Macklin","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2024.02.042_b0055","unstructured":"Global Polio Eradication Initiative. Global WPV1 and cVDPV cases. https:\/\/polioeradication.org\/polio-today\/. (accessed on 20 September 2023)."},{"issue":"12","key":"10.1016\/j.vaccine.2024.02.042_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofab535","article-title":"Circulation of Type 2 Vaccine-Derived Poliovirus in China in 2018\u20132019","volume":"8","author":"Zhao","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.042_b0065","unstructured":"World Health Organization. Guidelines for WHO\/EPI collaborative studies on poliomyelitis: standard procedure for determining immunity to poliovirus using the microneutralization test. https:\/\/iris.who.int\/handle\/10665\/70486 (accessed on 11 February 2024)."},{"key":"10.1016\/j.vaccine.2024.02.042_b0070","unstructured":"World Health Organization. Guidelines on clinical evaluation of vaccines: regulatory expectations. WHO Technical Report Series 1004, Annex 9, 2017:503-73. https:\/\/www.who.int\/publications\/m\/item\/WHO-TRS-1004-web-annex-9."},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.042_b0075","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.vaccine.2018.11.020","article-title":"Evaluation of the genetic stability of Sabin strains and the consistency of inactivated poliomyelitis vaccine made from Sabin strains using direct deep-sequencing","volume":"37","author":"Deng","year":"2019","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2024.02.042_b0080","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1093\/infdis\/jiw433","article-title":"Phase 3 trial of a sabin strain\u2013based inactivated poliovirus vaccine","volume":"214","author":"Liao","year":"2016","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2024.02.042_b0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/infdis\/jir723","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine made from sabin strains: A phase II, randomized, positive-controlled trial","volume":"205","author":"Liao","year":"2012","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2024.02.042_b0090","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1586\/erv.11.51","article-title":"Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains","volume":"10","author":"Verdijk","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"10.1016\/j.vaccine.2024.02.042_b0095","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0092-1157(86)90028-4","article-title":"Inactivation of poliovirus with beta-propiolactone","volume":"14","author":"Jiang","year":"1986","journal-title":"J Biol Stand"},{"issue":"9","key":"10.1016\/j.vaccine.2024.02.042_b0100","first-page":"1195","article-title":"Immuno-persistence of inactivated poliomyelitis vaccine in infants in China","volume":"25","author":"Ying","year":"2012","journal-title":"Chin J Biologicals"},{"issue":"4","key":"10.1016\/j.vaccine.2024.02.042_b0105","first-page":"317","article-title":"Survey of Serological Effect on Boost Vaccination of Inactivated Poliovirus Vaccine for Infants","volume":"17","author":"Ying","year":"2011","journal-title":"Chinese Journal of Vaccines and Immunization"},{"issue":"22","key":"10.1016\/j.vaccine.2024.02.042_b0110","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.vaccine.2023.03.012","article-title":"Immunogenicity and immune persistence in 4-year-old children completing four doses of Sabin strain or wild strain inactivated poliovirus vaccine: A phase IV, open-labeled, parallel-controlled observational study","volume":"41","author":"Chu","year":"2023","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2024.02.042_b0115","doi-asserted-by":"crossref","first-page":"517","DOI":"10.15585\/mmwr.mm7219a3","article-title":"Wassilak S.G.F.,Bolu O. Progress Toward Poliomyelitis Eradication \u2013 Worldwide, January 2021-March 2023","volume":"72","author":"Lee","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.02.042_b0120","first-page":"173","article-title":"Limitation of fecal and pharyngeal poliovirus excretion in Salk-vaccinated children. A family study during a type 1 poliomyelitis epidemic","volume":"76","author":"Marine","year":"1962","journal-title":"Am J Hyg"},{"issue":"10","key":"10.1016\/j.vaccine.2024.02.042_b0125","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/cid\/cix110","article-title":"Immune Serum From Sabin Inactivated Poliovirus Vaccine Immunization Neutralizes Multiple Individual Wild and Vaccine-Derived Polioviruses","volume":"64","author":"Sun","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.042_b0130","doi-asserted-by":"crossref","unstructured":"Yang H, Qi Q, Zhang Y, Wen N, Cao L, Liu Y, et al. China cVDPV2 Response Experts Group. Analysis of a Sabin-Strain Inactivated Poliovirus Vaccine Response to a Circulating Type 2 Vaccine-Derived Poliovirus Event in Sichuan Province, China 2019-2021. JAMA Netw Open 2023;6(1):e2249710. doi: 10.1001\/jamanetworkopen.2022.49710.","DOI":"10.1001\/jamanetworkopen.2022.49710"},{"key":"10.1016\/j.vaccine.2024.02.042_b0135","unstructured":"World Health Organization. Polio vaccines: WHO position paper\u2013June 2022. Weekly Epidemiological Record, 2022, 97:277-300. https:\/\/www.who.int\/publications\/i\/item\/WHO-WER9725-277-300. (accessed on 8 February 2024)."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24002019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24002019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T10:41:26Z","timestamp":1714992086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24002019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0264410X24002019"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and lot-to-lot consistency of booster shot with Sabin inactivated poliomyelitis vaccine in Chinese children aged 18\u201324 Months: A phase \u2163 clinical trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}